| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2001 | CN1070698C Medicinal treatment |
| 09/12/2001 | CN1070697C Method of preparing novel microcapsule |
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288277 Drugs, antiarthritic agants, antihistamines for treatment of asthma |
| 09/11/2001 | US6288267 Thioamide derivatives |
| 09/11/2001 | US6288250 Compounds |
| 09/11/2001 | US6288249 Carbocyclic alcohols |
| 09/11/2001 | US6288247 Catalytic multistage process forming a racemic mixture of compounds |
| 09/11/2001 | US6288241 Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 09/11/2001 | US6288237 Plant protection. immunosuppression and/or be used to combat malignant tumours; they are particularily preferred as cytostatic agents. |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288223 Process for the selective preparation of Z-isomers of 3-2(substituted vinyl)cephalosporins |
| 09/11/2001 | US6288128 β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound |
| 09/11/2001 | US6288127 Adding lewis acid inhibitor |
| 09/11/2001 | US6288126 Biphenyl compounds and use thereof as oestrogenic agents |
| 09/11/2001 | US6288125 Treatment of hiatial hernia |
| 09/11/2001 | US6288124 Methods of inhibiting undesirable cell growth using an aminoguanidine compound |
| 09/11/2001 | US6288123 Therapeutic guanidines |
| 09/11/2001 | US6288122 Gardos channel antagonists |
| 09/11/2001 | US6288121 Nimesulide topical formulations in the form of liquid crystals |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288119 11,15-O-dialkylprostaglandin E derivatives, process for producing the same, and drugs containing the same as the active ingredient |
| 09/11/2001 | US6288118 Therapies for treating pulmonary diseases |
| 09/11/2001 | US6288117 Administering triiodothyronine(t3) |
| 09/11/2001 | US6288116 Administering mixture containing protein, fats, vitamins, carbohydrates and minerals and arginine and an arginine-neutralizing acid selected from lactic, malic and adipic acids or mixtures |
| 09/11/2001 | US6288115 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 09/11/2001 | US6288114 Method of altering nutritional components of milk produced by a lactating animal |
| 09/11/2001 | US6288113 Angiogenesis promoters |
| 09/11/2001 | US6288112 Use of pyrethroid compounds to promote hair growth |
| 09/11/2001 | US6288111 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/11/2001 | US6288110 Pharmaceutical compositions comprising disulfiram |
| 09/11/2001 | US6288109 Pyranones, method for the production and use thereof |
| 09/11/2001 | US6288108 Methods for increasing levels of acetylcholine |
| 09/11/2001 | US6288107 Sulfatase inhibitors |
| 09/11/2001 | US6288106 Administering a metal-alpha-lipoic acid as a hypotensive agent, antidiabetic agents and vasoconstrictors, and to treat vision defects, alzheimer*s disease, parkinson*s disease, cardiovascular disorders and brain disorders |
| 09/11/2001 | US6288105 Antithrombotic agents |
| 09/11/2001 | US6288104 Administering seretonin uptake inhibitors to treat depression, psychological and psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders |
| 09/11/2001 | US6288103 Monocyte chemoattractant proteins antagonist such as n-(3-chlorophenylsulphonyl)indole-2-carboxylic acid; antiinflammatory agents |
| 09/11/2001 | US6288101 Imidazoles with serotonin receptor binding activity |
| 09/11/2001 | US6288100 Benzimidazole derivatives |
| 09/11/2001 | US6288098 Administering n-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide and n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 09/11/2001 | US6288096 Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| 09/11/2001 | US6288095 Compounds |
| 09/11/2001 | US6288092 Triaryl compounds |
| 09/11/2001 | US6288090 Pharmaceutical composition |
| 09/11/2001 | US6288089 Administering a composition of pyridyl imidazole compounds to treat parkinson's disease, huntington's disease, alzheimer's disease, and amyotophic lateral sclerosis |
| 09/11/2001 | US6288087 An extract from eupatorium purpurem, cytochrome p450 inducing compound, sugar, a source of phosphate, and one or more carriers |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288085 Piperidine derivatives for treating psychoses |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288081 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 09/11/2001 | US6288080 High speed absorption in blood; nonprecipitating |
| 09/11/2001 | US6288079 Tropane-derivatives, their preparation and use |
| 09/11/2001 | US6288078 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/11/2001 | US6288077 2,3-methano-amino acid compounds |
| 09/11/2001 | US6288076 Antimicrobial compositions |
| 09/11/2001 | US6288074 Method of treating lymphoproliferative syndrome |
| 09/11/2001 | US6288073 Acronycine derivatives, preparation method and pharmaceutical compositions |
| 09/11/2001 | US6288069 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 09/11/2001 | US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents |
| 09/11/2001 | US6288067 Prophylactic or therapeutic agents for drug-induced renal injury |
| 09/11/2001 | US6288066 Antidiabetic agents; oxidation, hydrolysis |
| 09/11/2001 | US6288062 Interleukin and tumor necrosis factor inhibitors; antiinflammatory agents; rheumatic diseases; antiarthritic agents; respiratory system disorders |
| 09/11/2001 | US6288060 Corticotropin releasing factor antagonists; anxiolytic, antidepressant, antiinflammatory agents; eating disorders |
| 09/11/2001 | US6288058 Treating muscular, nervous system, psychological and gastrointestinal disorders |
| 09/11/2001 | US6288057 Physical form of dihydro-2,3-benzodiazepine derivative |
| 09/11/2001 | US6288056 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288054 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 09/11/2001 | US6288053 Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy |
| 09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
| 09/11/2001 | US6288050 Steroid sulfatase inhibitors and methods for making and using the same |
| 09/11/2001 | US6288049 Cellulose and nonionic surfactant increase redispersibility and prevent aggregation |
| 09/11/2001 | US6288048 Cholesterol and hedgehog signaling |
| 09/11/2001 | US6288047 Lipid-based immune modulator composition |
| 09/11/2001 | US6288046 Acetylated alpha-linked acidic dipeptidase/n-/ inhibitors; carboxyalkylphosphates; prostate disorders; glutamate abnormalities; nervous system disorders |
| 09/11/2001 | US6288045 Administering 4,6 cyclo, trisilico, trimagnesium, trialumino, oxyo trihydrate acetate; side effect reduction |
| 09/11/2001 | US6288044 O-sulfated bacterial polysaccharides |
| 09/11/2001 | US6288039 Administering uteroglobin as anticarcinogenic and antimetastasis agent |
| 09/11/2001 | US6288037 C-terminally modified pentapeptides containing valine and aspartic acid |
| 09/11/2001 | US6288033 Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| 09/11/2001 | US6288030 Lyophilized formulation of stem cell factor (scf) mixed with histidine as stabilizing buffer |
| 09/11/2001 | US6287860 Antisense inhibition of MEKK2 expression |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287827 Fermentation of nocardia; administered to treat drug or antibiotic resistant grampositive bacterial infections |
| 09/11/2001 | US6287757 Amino acid-trehalose composition |
| 09/11/2001 | US6287693 Stable shaped particles of crystalline organic compounds |
| 09/11/2001 | US6287609 Unfermented gel fraction from psyllium seed husks |
| 09/11/2001 | US6287607 Bone loss |
| 09/11/2001 | US6287606 Methods of enhancing wound healing and tissue repair |
| 09/11/2001 | US6287602 Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent |
| 09/11/2001 | US6287601 Equine laminitis |
| 09/11/2001 | US6287599 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| 09/11/2001 | US6287598 Method for providing sustained antiepileptic therapy |
| 09/11/2001 | US6287597 Antihistaminic/decongestant compositions |
| 09/11/2001 | US6287594 Oral liquid compositions |
| 09/11/2001 | US6287593 Anticancer |
| 09/11/2001 | US6287592 Aqueous drink composition comprising ibuprofen |